Mor George Adi
SEC insider (Form 3/4/5 filer). CIK 0001851069. Chief Executive Officer at Chemomab Therapeutics Ltd. (CMMB). 4 reported Form 4/5 transactions since Sep 2024; latest on May 29, 2026. Located in TEL AVIV.
Companies Mor George Adi has filed insider reports for
- Chemomab Therapeutics Ltd. (CMMB): Director, Officer, Chief Executive Officer
Mor George Adi
CIK: 0001851069
Transaction Breakdown
Open Market Buys (P)2 (50.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)2 (50.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CMMB
Chemomab Therapeutics Ltd.
DirectorOfficer
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- May 29, 2026CMMB
Chemomab Therapeutics Ltd.
PurchaseDirect4.9K shares at avg. $2.05$10K - May 29, 2026CMMB
Chemomab Therapeutics Ltd.
PurchaseDirect4.9K shares at avg. $2.08$10K - May 29, 2026CMMB
Chemomab Therapeutics Ltd.
OtherDirect31.7K shares- - May 29, 2026CMMB
Chemomab Therapeutics Ltd.
OtherDirect18.8K shares-
1-4 of 4 transactions